HORIBA, Ltd.

6856.T
Scientific & Technical Instruments
2026/06/15 Updated
Market Cap: $6.7B (¥1.1T)
Stock Price: $158.78 (¥25,445)
Exchange Rate: 1 USD = ¥160.26

Stock Price Chart

2026/06/15 Updated
28.90
PER (Price Earnings Ratio)
vs Industry Avg: +19.4
3.10
PBR (Price to Book Ratio)
vs Industry Avg: +1.8
1.18%
Dividend Yield
vs Industry Avg: -1.77%

Price Trend

2026/06/15 Updated
Short-term
5-Day MA
+2.07%
Near-term
25-Day MA
+0.24%
Mid-term
75-Day MA
+16.89%
Long-term
200-Day MA
+47.88%

Price & Trading Details

2026/06/15 Updated

PRICE

Previous Close ¥24,800
Open ¥25,500
High ¥26,190
Low ¥25,300
Close ¥25,445

TRADING

Volume 187,100
Average Volume 192,125
Turnover ¥48億
Min. Purchase ¥2,544,500

Analyst Recommendations 7 analysts

Updated 2026/06/05
Strong Buy
1
1
Buy
5
5
Hold
1
1
Sell
0
Strong Sell
0
Target Price (Mean)
¥24,071
Strong Buy
¥35,000
High
¥26,000
Median
¥14,000
Low
+51% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/06/05
9.4%
Insider Holdings
49.3%
Institutional
41.3%
Public Float
161
Institutional Holders
Insider Holdings 9.4%
Institutional 49.3%
Public Float 41.3%

Top Mutual Funds / ETFs

Updated 2026/06/05

Major Holders

Updated 2026/06/05
Fund Name Ownership Shares Change
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.30%
550.9K 0.00%
T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Discovery Fd.
0.98%
412.1K -3.67%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.85%
359.8K +2.24%
HARTFORD MUTUAL FUNDS INC/CT-The Hartford International Value Fund
0.64%
270.3K -40.95%
Third Avenue Trust-THIRD AVENUE VALUE FUND
0.57%
239.5K -28.74%
iShares Trust-iShares Core MSCI EAFE ETF
0.54%
227.3K 0.00%
Institution Ownership Shares Change
Fifth Lane Capital, LP
<0.01%
1.8K +1.00%

Dividend History 1Years Growth

Updated 2026/06/14
-%
Dividend Yield
¥450
Annual Dividend
+66.7%
YoY Growth
51.2%
Payout Ratio
Year Dividend Change
2025 ¥450 +66.7%
2024 ¥270 -6.9%
2023 ¥290 +18.4%
2022 ¥245 +63.3%
2021 ¥150 -

Financial Performance

2026/06/14 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2021 2022 2023 2024
Income Statement
Revenue ¥224,314M ¥270,133M ¥290,558M ¥317,369M
Gross Profit ¥93,222M ¥116,674M ¥127,383M ¥136,854M
Operating Income ¥32,047M ¥45,844M ¥47,297M ¥48,340M
Pretax Income ¥30,720M ¥47,929M ¥54,425M ¥49,756M
Net Income ¥21,311M ¥34,072M ¥40,302M ¥33,591M
EPS ¥502.46 ¥802.89 ¥948.83 ¥795.34
Operating Margin 14.29% 16.97% 16.28% 15.23%
Balance Sheet
Total Assets ¥371,585M ¥416,742M ¥449,030M ¥481,616M
Total Equity ¥204,479M ¥240,833M ¥283,713M ¥314,688M
Total Liabilities ¥167,106M ¥175,909M ¥165,317M ¥166,928M
Cash ¥135,023M ¥139,855M ¥132,775M ¥144,272M
Interest-bearing Debt ¥80,184M ¥67,205M ¥60,394M ¥64,404M
Equity Ratio 55.03% 57.79% 63.18% 65.34%
D/E Ratio 0.39 0.28 0.21 0.20
Cash Flow
Operating CF ¥35,268M ¥33,966M ¥16,652M ¥40,335M
Investing CF -¥14,662M -¥10,745M -¥7,315M -¥17,562M
Financing CF -¥4,045M -¥22,447M -¥20,963M -¥15,933M
Free CF ¥22,696M ¥21,883M ¥7,481M ¥20,888M
Efficiency
ROE 10.42% 14.15% 14.21% 10.67%
ROA 5.74% 8.18% 8.98% 6.97%

Latest IR Information

Company Information

English Name HORIBA, Ltd.
Japanese Name (株)堀場製作所
Stock Code 6856.T (JPX)
Sector / Industry Technology / Scientific & Technical Instruments
Employees 9,101

About

HORIBA, Ltd., together with its subsidiaries, provides analytical and measurement solutions in Japan, Asia, the United States, and Europe. It operates in three segments: Energy and Environment; Bio and Healthcare; and Advanced Materials and Semiconductor. The company offers mobility products, including systems for emissions measurement, internal combustion engine testing, driveline and powertrain evaluation, brake testing, and wind tunnels; and energy and environment solutions for water and liquid, industrial process, and energy. It also provides life science products comprising fluorescence spectroscopy, raman imaging and spectrometers, and particle characterization; healthcare solutions, which include vitro diagnostic systems for biological analysis, clinical chemistry, veterinary, hematology, and hemostasis; material analysis, such as elemental analysis, molecular and structural analysis, and surface analysis and thin film characterization; and semiconductor products. In addition, the company offers technology solutions comprising health care, fluid control, mass spectrometry, spectroscopy, microscopy and imaging, electrochemistry, physisorption, particle and element analysis, and surface plasmon resonance; and services, including analysis centers, calibration and certification, customer support, spare parts and consumables, testing and consulting, and product and technology training. Its products are used in arts, entertainment, and recreation; biopharma and pharma, biotechnology and biomedical; cosmetics; education, research and development, and government institution; energy solutions; food and beverage; healthcare; industrials; information technology; materials; mobility and transportation; waste management; and water applications. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.

Data provided by Yahoo Finance